These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 55892)

  • 1. Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.
    Powles TJ; Dowsett M; Easty GC; Easty DM; Neville AM
    Lancet; 1976 Mar; 1(7960):608-10. PubMed ID: 55892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer.
    Powles TJ; Clark SA; Easty DM; Easty GC; Neville AM
    Br J Cancer; 1973 Oct; 28(4):316-21. PubMed ID: 4759939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer.
    Powles TJ
    Proc R Soc Med; 1977 Mar; 70(3):199-201. PubMed ID: 323867
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro osteolysis by human breast tumours.
    Easty GC; Dowsett M; Powles TJ; Easty DM; Gazet JC; Neville AM
    Proc R Soc Med; 1977 Mar; 70(3):191-5. PubMed ID: 193116
    [No Abstract]   [Full Text] [Related]  

  • 5. Human breast tumour-induced osteolysis and prostaglandins.
    Dowsett M; Easty GC; Powles TJ; Easty DM; Neville AM
    Prostaglandins; 1976 Mar; 11(3):447-60. PubMed ID: 948618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of indomethacin to reduce hypercalcemia in patients with breast cancer.
    Coombes RC; Neville AM; Bondy PK; Powles TJ
    Prostaglandins; 1976 Dec; 12(6):1027-35. PubMed ID: 1005735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
    Sasaki A; Boyce BF; Story B; Wright KR; Chapman M; Boyce R; Mundy GR; Yoneda T
    Cancer Res; 1995 Aug; 55(16):3551-7. PubMed ID: 7627963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteolytic metastases.
    Lancet; 1976 Nov; 2(7994):1063-4. PubMed ID: 62905
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandins and breast cancer.
    Bennett A; Charlier EM; McDonald AM; Simpson JS; Stamford IF; Zebro T
    Lancet; 1977 Sep; 2(8039):624-6. PubMed ID: 71446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer, prostaglandins, and bone metastases.
    Bennett A; McDonald AM; Simpson JS; Stamford IF
    Lancet; 1975 May; 1(7918):1218-20. PubMed ID: 48837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2.
    Lau WM; Weber KL; Doucet M; Chou YT; Brady K; Kowalski J; Tsai HL; Yang J; Kominsky SL
    Int J Cancer; 2010 Feb; 126(4):876-84. PubMed ID: 19642106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
    J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse tumor-derived osteolytic factor stimulates bone resorption by a mechanism involving local prostaglandins production in bone.
    Lau KH; Lee MY; Linkhart TA; Mohan S; Vermeiden J; Liu CC; Baylink DJ
    Biochim Biophys Acta; 1985 May; 840(1):56-68. PubMed ID: 2986710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
    Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
    Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of bone metastasis formation].
    Peyruchaud O
    J Soc Biol; 2007; 201(3):229-36. PubMed ID: 18157074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
    Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
    PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.